Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
610 Results Found
AHA files friend-of-the-court brief defending Louisiana 340B contract pharmacy law
AHA Dec. 22 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.
AHA 340B Alliance Bulletin: November 29, 2023
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
Resources to Address 340B Underpayments by Medicare Advantage Organizations
To assist members in their efforts to obtain reimbursement under their contracts with their MAO plans, we have identified and spoken with four outside law firms that have considerable experience with 340B questions and litigating against insurers on issues like these.
Talking Points — Ensuring the Protection of the Vital 340B Program for Patients and Providers
Ensuring the Protection of the Vital 340B Program for Patients and Providers
Advocacy Issue: 340B Drug Pricing Program
The 340B program has worked successfully for over 30 years to allow eligible providers to stretch limited federal resources to provide more comprehensive programs and services to more patients. This is exactly what Congress intended when it created the program in 1992.
Grady Health System | Georgia
Grady Health System – comprised of Grady Memorial Hospital, a children’s hospital, and ten outpatient care centers – is a health care anchor for the Atlanta community. The 340B Drug Pricing Program is essential to preserving Grady’s ability to provide high-quality, patient-centered care to all, no matter their ability to pay.
HHS Issues Final Remedy for Its Unlawful 340B Payment Cuts from 2018 to 2022
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
HHS issues final remedy for its unlawful 340B payment cuts from 2018 to 2022
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
AHA Statement on Final 340B Remedy
Following years of litigation and a unanimous Supreme Court win, the AHA is very pleased that 340B hospitals finally will be reimbursed in full for what HHS unlawfully withheld from them for five years.
HRSA clarifies policy regarding registration requirements for 340B ‘child sites’
The Health Resources and Services Administration will require hospitals in the 340B Drug Pricing Program to register their off-site outpatient departments with the 340B Office of Pharmacy Affairs within 90 days.